CIRC

CIRC Announces 2023 Annual Results

Retrieved on: 
Wednesday, April 17, 2024
Carbon, Medicine in China, Growth, Development, Diagnosis, Technetium, Radiant, BFT, First Prize, National security, National Medical Products Administration, Conference, CIRC, International, Insurance, Safety, Health, Nuclear medicine, Research, XV, Shenzhou, Radiopharmaceutical, Marketing, Clinical trial, Smart, BINE, Patent, EB, Cancer, Bank statement, The Company, Medical imaging

HONG KONG, Apr 17, 2024 - (ACN Newswire) - China Isotope & Radiation Corporation ("CIRC" or the "Company" , together with its subsidiaries, the "Group"; Stock Code: 1763.HK) announces the audited consolidated financial statements of the Group for the year ended 31 December 2023 ("2023" or the "Reporting Period").

Key Points: 
  • HONG KONG, Apr 17, 2024 - (ACN Newswire) - China Isotope & Radiation Corporation ("CIRC" or the "Company" , together with its subsidiaries, the "Group"; Stock Code: 1763.HK) announces the audited consolidated financial statements of the Group for the year ended 31 December 2023 ("2023" or the "Reporting Period").
  • For the year ended 31 December 2023, the Group operated five business segments, namely pharmaceuticals, radioactive source products, irradiation, radiation therapy equipment and related services and other businesses.
  • In 2023, the Group continued to intensify our market development efforts and achieved continued growth in economic efficiency.
  • As of 31 December 2023, the Group had a number of imaging diagnosis and therapeutic radiopharmaceuticals under research and development.

Takeda Supports the Canadian IBD Research Consortium's $1 Million Pioneer Grant for Second Year

Retrieved on: 
Tuesday, February 13, 2024
Ulcerative colitis, Crohn's disease, Randomized controlled trial, Letter, Physician, Quality of life, McGill University, EST, Inflammatory bowel disease, Associate, Patient, CIRC, RCT, IBD, Disease, Research, Partnership

TORONTO, Feb. 13, 2024 /CNW/ - Takeda Canada Inc. (Takeda) is pleased to announce its support of the Canadian Inflammatory Bowel Disease Research Consortium's (CIRC) $1 million PIONEER Grant in its second year.

Key Points: 
  • TORONTO, Feb. 13, 2024 /CNW/ - Takeda Canada Inc. (Takeda) is pleased to announce its support of the Canadian Inflammatory Bowel Disease Research Consortium's (CIRC) $1 million PIONEER Grant in its second year.
  • This grant, with Takeda contributing $500,000 of the $1,000,000 award, will continue to support high-quality, impactful Canadian clinical research to improve patient outcomes and quality of life for people living with inflammatory bowel disease (IBD).
  • "We are immensely proud of our research community, this program and are grateful for Takeda partnership and dedication to advancing research in Canada."
  • "The PIONEER Grant, established through $1,000,000 in support from Takeda, gives Canadian IBD researchers an amazing and truly unique opportunity to conduct practice changing investigator-initiated research.

AI Identifies Non-smokers at High Risk for Lung Cancer

Retrieved on: 
Wednesday, November 22, 2023
Deep learning, Medicine, Lung, Health, RSNA, Smoker, Research, MGH, National academy, Incidence, American Cancer Society, National Comprehensive Cancer Network, Risk, Disease, Hospital, Mortality, Serum, B.A, Patient, Respiratory tract infection, Tobacco, Smoke, Artificial intelligence, Knowledge Organization (journal), Non-Smokers' Rights Association, USPSTF, Prostate, Lung cancer screening, Lung cancer, Newsroom, Harvard Medical School, Diagnosis, CIRC, Massachusetts General Hospital, Medicare, Chronic obstructive pulmonary disease, Biomarker, Cancer, Society, Radiology, Radiation, Education, Risk management, Medical imaging, Boston

The American Cancer Society estimates about 238,340 new cases of lung cancer in the United States this year and 127,070 lung cancer deaths.

Key Points: 
  • The American Cancer Society estimates about 238,340 new cases of lung cancer in the United States this year and 127,070 lung cancer deaths.
  • Existing lung cancer risk scores require information that is not readily available for most individuals, such as family history of lung cancer, pulmonary function testing or serum biomarkers.
  • For the study, CIRC researchers set out to improve lung cancer risk prediction in never-smokers by testing whether a deep learning model could identify never-smokers at high risk for lung cancer, based on their chest X-rays from the electronic medical record.
  • The high-risk group well exceeded the 1.3% six-year risk threshold where lung cancer screening CT is recommended by National Comprehensive Cancer Network guidelines.

Eco-Products Unveils New Program to Help Prevent Contamination in Compost Streams

Retrieved on: 
Monday, October 9, 2023
Restaurant, Haulage, Marketing, Control, CIRC, Communication, Compost, Landfill, Poultry farming, Recycling

BOULDER, Colo., Oct. 9, 2023 /PRNewswire/ -- Eco-Products® today announced an innovative new program to help foodservice operators keep non-compostable items out of their organics streams.

Key Points: 
  • The program, called Controls Intended to Remove Contamination (CIRC) , will verify that restaurants and other operators are taking important steps to prevent non-compostable materials from being sent to composting facilities.
  • "Contamination from non-compostable products is the defining challenge for many composters today," said Wendell Simonson, Director of Marketing at Eco-Products .
  • "Unfortunately, most composters have an extremely limited ability to deal with contamination once it gets to their facilities.
  • That's why foodservice operators must put controls in place to prevent that contamination from ever getting to composters in the first place."

Takeda Launches New App to Help Healthcare Professionals Keep Pace with Important Clinical Trial Data

Retrieved on: 
Tuesday, October 3, 2023
Bureau of Oceans and International Environmental and Scientific Affairs, Clinical trial, Takeda, IBD, Android, Computer, Tablet, Publication, Collection, Patient, Physician, Division, Apple, Hospital, Inflammatory bowel disease, Health, CIRC, Lexicon, Medical device, Nursing

TORONTO, Oct. 3, 2023 /CNW/ - Today, Takeda Canada Inc. ("Takeda") announced the launch of Clinical Trials (CT) Lexicon, an innovative app that provides healthcare professionals with a centralized library of key studies and data at their fingertips.

Key Points: 
  • TORONTO, Oct. 3, 2023 /CNW/ - Today, Takeda Canada Inc. ("Takeda") announced the launch of Clinical Trials (CT) Lexicon, an innovative app that provides healthcare professionals with a centralized library of key studies and data at their fingertips.
  • The initial launch of the app focuses on Inflammatory Bowel Disease (IBD) with additional clinical focus areas to be rolled-out at later stages.
  • Last year, Takeda founded the first $1 Million Pioneer Grant through the Canadian IBD Research Consortium (CIRC) in support of high-quality, impactful Canadian clinical research.
  • This year, Takeda helped establish Canadian IBD Today, to help ensure Canadian physicians can share real-world experiences in a Canadian setting with Canadian patients.

Takeda Opens Digital Health Innovation Challenge in Partnership with Plug and Play Alberta for Solutions to Improve Patient Care in Inflammatory Bowel Disease

Retrieved on: 
Thursday, June 1, 2023
Partnership, Crohn's disease, Bureau of Oceans and International Environmental and Scientific Affairs, Health, IBD, HCP, Patient, Ulcerative colitis, Physician, Artificial intelligence, Digital, Inflammatory bowel disease, Plug and play, CIRC, Pharmaceutical industry, Nursing, Takeda

In the second challenge, Takeda is collaborating with Plug and Play Alberta ("Plug and Play") to help broaden our reach and to harness their expertise in connecting innovative tech initiatives with large corporations to propel digital transformation.

Key Points: 
  • In the second challenge, Takeda is collaborating with Plug and Play Alberta ("Plug and Play") to help broaden our reach and to harness their expertise in connecting innovative tech initiatives with large corporations to propel digital transformation.
  • This year's challenge looks to identify best-in-class solutions with the potential to improve the patient or health care provider (HCP) experience in Inflammatory Bowel Disease (IBD), the most common forms being Ulcerative Colitis and Crohn's Disease.
  • "We are thrilled to launch our second Takeda Canada Digital Health Innovation Challenge.
  • The Takeda Canada Digital Health Innovation Challenge application period runs June 1 through June 24, 2023.

THE CANADIAN INFLAMMATORY BOWEL DISEASE RESEARCH CONSORTIUM AWARDS FIRST $1M PIONEER GRANT FROM TAKEDA CANADA

Retrieved on: 
Tuesday, November 8, 2022
Ulcerative colitis, IBD, UC, Crohn's disease, University, Volunteering, Takeda Pharmaceutical Company, Solution, CRO, Quality of life, Awareness, Risk, NYSE, Precision medicine, Impact, Hematology, Disease, Inflammation, Partnership, C1-inhibitor, Vaccine, Cumming School of Medicine, TAK, University of Calgary, TSE, Mathematical optimization, General manager, Crohn's and Colitis Canada, Clinical trial, CIRC, Pragmatism, R, Inflammatory bowel disease, Technology, Crohn's & Colitis Foundation, Genetics, Hospital, Patient, Ileum, Drug development, CD, Investment, Research, Pharmaceutical industry, Medical device, Facebook, Takeda, Colitis, Neuroscience, Gastroenterology

Funding will support the first active comparator, multicentre, randomized trial to evaluate optimal first-line treatment strategy for Ileal Crohn's disease

Key Points: 
  • Funding will support the first active comparator, multicentre, randomized trial to evaluate optimal first-line treatment strategy for Ileal Crohn's disease
    TORONTO, Nov. 8, 2022 /CNW/ - The Canadian Inflammatory Bowel Disease Research Consortium (CIRC) awards the inaugural $1 million PIONEER Grant from Takeda Canada Inc. (Takeda), in support of high-quality, impactful Canadian clinical research to improve patient outcomes and quality of life for people living with inflammatory bowel disease (IBD).
  • The grant awardee will also receive assistance from Alimentiv, a world-class research organization with deep expertise in conducting clinical trials in IBD, through expertise, research execution and in-kind support.
  • Ileal CD increases the risk for bowel damage so choosing the right medical treatment is critical for preventing complications like hospitalization and surgery.
  • "At Takeda, we are committed to advancing scientific research in the area of IBD and are proud to establish the CIRC PIONEER Grant to support Canadian researchers in their pursuit of life-changing innovations," said Rute Fernandes, General Manager, Takeda Canada.

Teledyne FLIR debuts SIRAS Drone for Public Safety and Industrial Inspection

Retrieved on: 
Tuesday, September 6, 2022
Technology, Photography, Law Enforcement, Emergency Services, Public Policy, Government, Drones, Audio, Video, Hardware, Robotics, Public Safety, Commerce, United States Department of Commerce, FLIR, NYSE, Commercial, UAV, Solution, Teledyne Technologies, EO, SD, Multimedia, TDY, EAR, CIRC, Quality control, Aircraft, Satellite navigation device

Teledyne FLIR, part of Teledyne Technologies Incorporated (NYSE:TDY), today launched SIRAS, a professional drone that includes a quick-connect dual radiometric thermal and visible camera payload.

Key Points: 
  • Teledyne FLIR, part of Teledyne Technologies Incorporated (NYSE:TDY), today launched SIRAS, a professional drone that includes a quick-connect dual radiometric thermal and visible camera payload.
  • Engineered for data security, performance, and affordability, SIRAS is optimized for industrial and utility inspection, public safety, firefighting, and search and rescue missions.
  • View the full release here: https://www.businesswire.com/news/home/20220906005214/en/
    Teledyne FLIR SIRAS is an affordable professional drone build with data security in mind.
  • It features a swappable quick connect thermal imaging and EO payload for public safety and industrial inspection uses.

Global Digital Sustainability and Resilience Top the Agenda for 5th Annual Great Canadian Data Centre Symposium

Retrieved on: 
Tuesday, July 12, 2022
SNF, CIRC, MIP, Leadership, Multimedia, McMaster University, YouTube, LinkedIn, Digital, IDCA, Globe, CEO, Resilience, Sustainability, GLOBE, IT infrastructure, RSVP, Research, Twitter, Carbon, McMaster, Renewable energy, Management

Calls for continuous uptime availability and never-fail resiliency are top of mind for digital infrastructure industry leaders everywhere.

Key Points: 
  • Calls for continuous uptime availability and never-fail resiliency are top of mind for digital infrastructure industry leaders everywhere.
  • The twin demands of sustainability and resilience in digital infrastructure will steer program planning for GCDCS 2022.
  • An IT and data centre Industry conference veteran, Taylor launched the original Uptime Institute Data Center Symposium and is former Data Centre Dynamics EVP for the US and Canada.
  • GCDCS collaborators invite members of the digital infrastructure community from across Canada and the globe to participate in the digital resilience and sustainability conversations at GCDCS22.

Global Digital Sustainability and Resilience Top the Agenda for 5th Annual Great Canadian Data Centre Symposium

Retrieved on: 
Tuesday, July 12, 2022
SNF, CIRC, MIP, Leadership, Multimedia, McMaster University, YouTube, LinkedIn, Digital, IDCA, Globe, CEO, Resilience, Sustainability, GLOBE, IT infrastructure, RSVP, Research, Twitter, Carbon, McMaster, Renewable energy, Management

Calls for continuous uptime availability and never-fail resiliency are top of mind for digital infrastructure industry leaders everywhere.

Key Points: 
  • Calls for continuous uptime availability and never-fail resiliency are top of mind for digital infrastructure industry leaders everywhere.
  • The twin demands of sustainability and resilience in digital infrastructure will steer program planning for GCDCS 2022.
  • An IT and data centre Industry conference veteran, Taylor launched the original Uptime Institute Data Center Symposium and is former Data Centre Dynamics EVP for the US and Canada.
  • GCDCS collaborators invite members of the digital infrastructure community from across Canada and the globe to participate in the digital resilience and sustainability conversations at GCDCS22.